2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Status
Completed
17
Recruiting
10
Terminated
5
Unknown
3
Not yet recruiting
3
Active not recruiting
3
Withdrawn
2
Suspended
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Lymphoid
1
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Hepatitis
1
Chemical and Drug Induced Liver Injury
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Cisplatin
512
Radiotherapy
376
Cyclophosphamide
361
Carboplatin
354
Capecitabine
341
Oxaliplatin
331
Paclitaxel
328
Gemcitabine
318
Docetaxel
314
Fluorouracil
288
Drug Therapy
271
apatinib
245
Bevacizumab
243
camrelizumab
217
Etoposide
200
Irinotecan
182
Doxorubicin
180
Leucovorin
160
Dexamethasone
160
pembrolizumab
150
sintilimab
143
Neoadjuvant Therapy
142
anlotinib
139
Pemetrexed
138
Cytarabine
138
Blood Specimen Collection
138
Surgical Procedures, Operative
130
toripalimab
128
Radiosurgery
127
S 1 (combination)
124
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Adrenal Cortex Hormones
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled
NCT00946374
2009-07-27
HD-MCL2003
Heidelberg University
Phase 2
Unknown
20 enrolled